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Abstract
Introduction: Early identification and management of chronic kidney disease (CKD) is highly cost-effective and can reduce the risk of kidney failure 
progression and cardiovascular disease. In 2014, the Joint Croatian Working Group (JCWG) for laboratory diagnostic of CKD on the behalf of Croatian 
society of medical biochemistry and laboratory medicine (CSMBLM) and Croatian chamber of medical biochemists (CCMB) conducted a survey across 
Croatian medical-biochemistry laboratories to assess the current practice in this area of laboratory medicine. The aim of this study was to present 
the data collected through the survey and to give insight about laboratory diagnostics of chronic kidney disease in Croatia.
Materials and methods: An invitation to participate in the survey was sent to all Croatian medical-biochemistry laboratories (N = 196). The que-
stionnaire was designed in a form of questions and statements, with possible multiple answers, comprising 24 questions. 
Results: The response rate was 80/196 (40.8%). 39 answers were from primary medical-biochemistry laboratories. 31/78 (0.40) laboratories mea-
sure creatinine with non-standardized method (uncompensated Jaffe method). 58/78 (0.74) of laboratories that measure creatinine do not report 
eGFR values. Similar number of laboratories (58/80, 0.73) do not measure urine albumin or protein. 
Conclusions: There is a large heterogeneity among Croatian laboratories regarding measuring methods, reporting units and reference intervals 
(cut-off values), both for creatinine and urine albumin or protein. The two key prerequisites for CKD screening, automatic reporting of eGFR and albu-
minuria or proteinuria assessment, are not implemented nationwide. There is a need for harmonization in laboratory diagnostics of CKD in Croatia.
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Chronic kidney disease (CKD) is a general term for 
heterogeneous disorders affecting kidney structu-
re and function with variable clinical presentati-
ons. The Kidney Disease: Improving Global Outco-
mes (KDIGO) CKD Working Group released new 
updated KDIGO 2012 Clinical Practice Guideline for 
the Evaluation and Management of Chronic Kid-
ney Disease which pointed on the relevance of la-
boratory medicine in diagnosis of CKD (1). Early 
identification and management of CKD is highly 
cost-effective and can reduce the risk of kidney fa-
ilure progression and cardiovascular disease by up 
to 50% and increasing the recognition of kidney 
damage is a key part of improving health outco-
mes in the community (2). The prerequisite for 
screening policies for chronic kidney disease is 
standardization of measurement of serum creati-
nine and automatic reporting of estimated glome-
rular filtration rate (eGFR) consequently as a mar-
ker of kidney function, and uniform assessment of 
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albuminuria (or proteinuria) type of sample used 
and reporting units as a marker of kidney damage, 
nationwide (3). In 2014 Joint Croatian Working Gro-
up (JCWG) for laboratory diagnostics of CKD on 
the behalf of Croatian society of medical bioche-
mistry and laboratory medicine (CSMBLM) and 
Croatian chamber of medical biochemists (CCMB) 
initiated proceedings to provide easily applicable 
national recommendations in this area of labora-
tory medicine. The initial step was to assess the cu-
rrent practice among Croatian laboratories in CKD 
evaluation, in order to set the background for de-
veloping national recommendations. The aim of 
this study was to assess the degree of adherence 
of medical laboratories in Croatia with KDIGO 2012 
Clinical Practice Guideline for the Evaluation and 
Management of Chronic Kidney Disease.
Materials and methods
Questionnaire
An e-mail invitation to participate in the on-line 
survey was sent to all Croatian medical biochemis-
try laboratories (N = 196). The e-mail was ad-
dressed to laboratory managers in order to avoid 
duplicate answers from one laboratory. The on-
line survey was performed using the SurveyMon-
key tool (Palo Alto, CA, USA), and it was held from 
April 3rd until May 20th 2014, with two reminders in 
that period of time. The survey was anonymous.
Questionnaire was designed in a form of questions 
and statements, with possible multiple answers 
and comprised 24 questions (Table 1). The inten-
tion was to provide data about current practice in 
Croatian medical biochemistry laboratories re-
garding laboratory tests for initial screening of 
CKD: creatinine, eGFR and albuminuria or protein-
uria. The questionnaire contained questions about 
all three phases of total testing process. Questions 
regarding preanalytical phase included preferred 
types of samples used for measuring urine albu-
min or protein. Analytical phase was covered with 
questions about methods, reagent manufacturer 
and instruments for measuring creatinine and 
urine albumin and protein, while postanalytical 
phase questions included specifying reference in-
tervals (or cut-offs) and units of measurement and 
reporting for: serum creatinine, urine albumin and 
urine protein. Additional questions about equa-
tions for calculating eGFR, as well as reporting 
eGFR were included in the survey.
Statistical analysis
Data were archived in Microsoft Excell 2010 pro-
gram (Microsoft. Microsoft Excel. Redmond, Wash-
ington: Microsoft, 2010. Computer Software). Re-
sults were provided by counting and presented as 
absolute numbers and percentages (or ratios). Dis-
tribution of answers subdivided into groups ac-
cording to type of institution was compared with 
Chi-square test. Statistical analysis was performed 
using MedCalc 9.4.2.0. statistical software (Med-
Calc Software, Mariakerke, Belgium). P < 0.05 was 
defined as the threshold of significance.
Results
Total of 80/196 (40.8%) laboratories answered the 
questionnaire, out of which almost half were from 
primary health-care institutions (39/80). 22 labora-
tories from general/county/special types of hospi-
tals answered the survey, 10 answers were from 
private laboratories (integral parts of private poli-
clinics) and there were nine responders from clini-
cal hospitals and clinical hospital centres. 
Creatinine
Only 2/80 laboratories do not measure serum cre-
atinine. The most prevalent method used for se-
rum creatinine measurement was compensated 
Jaffé method traceable to reference Isotope Dilu-
tion Mass Spectrometry (IDMS) method and The 
National Institute of Standards and Technology 
Standard Reference Material (NIST SRM) 967 for 
creatinine in serum (40/78). Distribution of meth-
ods used for serum creatinine measurements, sub-
divided by types of institutions, is shown in Table 
2. Comparison of methods across type of institu-
tions was performed by Chi-square test. Consider-
ing the fact that there were low frequencies in 
some fields, methods for creatinine measurement 
were divided in two categories: non-standardized 
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Questions Answers
General
1. Type of institution •	 primary health care
•	 private institution
•	 general / county / special hospital
•	 university hospital / university hospital centre
Methods
Creatinine
2. Do you measure serum creatinine? •	 yes (go to next question)
•	 no (go to question no.10)
3. Please specify your method for measuring serum creatinine (more than 
one may be selected):
•	 uncompensated Jaffe
•	 compensated Jaffe aligned with IDMS method
•	 enzymatic method aligned with IDMS method
•	 whole blood creatinine
•	 dry chemistry
•	 other (please specify)
4. Specify your reagent manufacturer(s)
5. Specify your type of instrument (s)
6. Specify reference interval for adults used for serum creatinine in your laboratory
eGFR
7. Do you automatically report the results of estimated Glomerular Filtration 
Rate (eGFR) along with the serum creatinine concentration?
•	 yes, automatically with every result of serum 
creatinine (go to next question)
•	 yes, only on doctors demand (go to next 
question)
•	 no (go to question no.10)
8. Which equation do you use for estimating GFR for routine reporting (more 
than one may be selected):
•	 MDRD equation for non-standardized creatinine
•	 MDRD equation for standardized creatinine 
•	 CKD-EPI equation
•	 Schwartz equation for paediatric patients
•	 other (please specify)
9. How do you report high results for eGFR greater than 60 mL/min/1,73 m2? •	 We report all values for eGFR as the exact number
•	 We report values above 60 mL/min/1.73 m2 as > 
60 mL/min/1,73 m2
•	 We report values above 90 mL/min/1.73 m2 as > 
90 mL/min/1.73 m2
•	 Other
Urine protein and albumin
10. Do you perform the following tests? •	 Urine protein
•	 Urine albumin
•	 no (go to question no.24)
11. Which is recommended sample for measuring urine protein? •	 24 hour urine sample
•	 random spot urine sample
•	 First morning spot urine sample
•	 both 24-hour urine and random urine sample
•	 not specified
•	 other (please specify)
Table 1. Questionnaire.
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Questions Answers
12. Which is recommended sample for measuring urine albumin? •	 24 hour urine sample
•	 random spot urine sample
•	 First morning sport urine sample
•	 both 24-hour urine and random urine sample
•	 not specified
•	 other (please specify)
13. Please specify the approximate numbers of samples received per month 
for the following:
•	 24 hour urine sample for total protein
•	 Spot sample for urine protein
•	 24 hour urine sample for urine albumin
•	 Other timed sample for urine albumin
•	 Spot sample for urine albumin





•	 other (please specify)
15. Specify your reagent manufacturer(s)
16. Specify your type of instrument(s)





•	 other (please specify)
18. Specify your reagent manufacturer(s)
19. Specify your type of instrument(s)









21. Please specify your reference interval (cut-off value) for urine albumin:







23. Please specify your reference interval (cut-off value) for urine protein:
Education
24. Are you interested in further education in the field of implementation of 
clinical guidelines into every day routine practice?
•	 yes
•	 no 
uncompensated Jaffé method and standardized 
methods (compensated Jaffé and enzymatic 
methods). This comprised our distribution table 
into 2 X 4 table. There was no statistically signifi-
cant difference in distribution of methods by type 
of institution, P = 0.564. However, it is worth to 
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aligned with IDMS 
method
Dry chemistry
Primary health care 16 22 1 0 0
Private institution 4 6 0 0 0
General / county / special 
hospital 7 8 3 3 0
University hospital / 
university hospital centre 4 0 2 1 1
IDMS – Isotope dilution mass spectrometry
Table 2. Distribution of methods for serum creatinine measurement by type of medical biochemistry laboratory in Croatia (N = 78).
emphasize that only one laboratory among prima-
ry health care laboratories, and none of the private 
laboratories, determine serum creatinine using en-
zymatic method. 
The majority of laboratories (73/78) are using ref-
erence intervals according to the recommenda-
tions from the CCMB (4). However, a large propor-
tion (16/78, 0.20) of laboratories are using incorrect 
reference intervals according to the stated meth-
od used for serum creatinine measurement. Five 
laboratories measure creatinine with uncompen-
sated Jaffé method, but their reference intervals 
are for standardized creatinine. Eleven laboratories 
determine creatinine with standardized method 
(compensated Jaffé or enzymatic), but they are us-
ing reference intervals for non-standardized cre-
atinine. 
The most prevalent manufacturers of reagents 
used for serum creatinine measurement are Beck-
man Coulter (Beckman Coulter, Inc., Pasadena, Cal-
ifornia, USA) (34/78) and Roche (F.Hoffmann-La 
Roche, Basel, Switzerland) (28/78). Other reagents 
used were from the listed manufacturers: Siemens 
(Siemens AG, Berlin, Germany) (6/78), Herbos (Her-
bos d.d., Sisak, Croatia) (3/78), Diasys (DiaSys Diag-
nostic Systems GmbH, Holzheim, Germany) (3/78), 
Abbott (Abbott Laboratories, IL, USA) (2/78), Hu-
man (Human, Wiesbaden, Germany) (1/78) and Or-
tho Clinical Diagnostics (Ortho Clinical Diagnostics 
Inc., USA) (1/78). Only 10 out of 78 laboratories de-
termine serum creatinine concentration using en-
zymatic method traceable to IDMS reference 
method. Six of them are using reagents from Beck-
man Coulter, and four of them Roche reagents.
eGFR
The majority of laboratories generally do not re-
port results for eGFR (58/78). There was a statisti-
cally significant difference in distribution of labo-
ratories that report eGFR by type of institution (P < 
0.001), with the lowest number of laboratories 
from primary health care institutions (Figure 1.).
Description of equations used for calculating 
eGFR by type of medical biochemistry laboratory, 
Figure 1. Comparison of number of laboratories that report 
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Equation used for 




aligned with IDMS 
method
MDRD equation for 
standardized creatinine
Values above 60 mL/






aligned with IDMS 
method
MDRD equation for 
standardized creatinine
Values above 60 mL/





aligned with IDMS 
method
Creatinine clearance -
The respondent did not notice 
the distinction between 
measured and estimated GFR
Private institution
Compensated Jaffe 
aligned with IDMS 
method
MDRD equation for 
standardized creatinine
All values for eGFR report 
as the exact number
Limitation of MDRD equation for 
values above 60 mL/min/1.73 m2
Private institution
Compensated Jaffe 
aligned with IDMS 
method
MDRD equation for 
standardized creatinine
All values for eGFR report 
as the exact number
Limitation of MDRD equation for 
values above 60 mL/min/1.73 m2
Private institution
Compensated Jaffe 
aligned with IDMS 
method
MDRD equation for 
standardized creatinine
All values for eGFR report 
as the exact number
Limitiation of MDRD equation for 
values above 60 mL/min/1.73 m2
General / county / 
special hospital
Compensated Jaffe 
aligned with IDMS 
method
MDRD equation for 
standardized creatinine
Values above 60 mL/
min/1.73 m2 report as 
>60 mL/min/1.73 m2
-
General / county / 
special hospital
Compensated Jaffe 
aligned with IDMS 
method
MDRD equation for 
standardized creatinine
All values for eGFR report 
as the exact number The obvious discrepancy 
between way of reporting 
eGFR using MDRD and CKD-EPI 
equation
Wrong method for calculating 
eGFR with Schwartz equation
CKD-EPI equation
Values above 60 mL/
min/1.73 m2 report as 
>60 mL/min/1.73 m2
Schwartz equation for 
paediatric patients
General / county / 
special hospital
Compensated Jaffe 
aligned with IDMS 
method
CKD-EPI equation
All values for eGFR report 
as the exact number
Wrong method for calculating 
eGFR with Schwartz equationSchwartz equation for 
paediatric patients
General / county / 
special hospital Uncompensated Jaffe
Schwartz equation for 
paediatric patients
All values for eGFR report 
as the exact number
Wrong method for calculating 
eGFR with Schwartz equation
General / county / 
special hospital
Compensated Jaffe 
aligned with IDMS 
method
MDRD equation for 
standardized creatinine
Values above 60 mL/
min/1.73 m2 report as > 
60 mL/min/1.73 m2
-
General / county / 
special hospital
Enzymatic method 
aligned with IDMS 
method
MDRD equation for 
standardized creatinine
Values above 60 mL/
min/1.73 m2 report as 
>60 mL/min/1.73 m2
-
General / county / 
special hospital
Compensated Jaffe 
aligned with IDMS 
method
MDRD equation for 
standardized creatinine
Values above 60 mL/
min/1.73 m2 report as 
>60 mL/min/1.73 m2
-
General / county / 
special hospital
Compensated Jaffe 
aligned with IDMS 
method
MDRD equation for 
standardized creatinine All values for eGFR report 
as the exact number
Limitation of MDRD equation for 
values above 60 mL/min/1.73 m2
Wrong method for calculating 
eGFR with Schwartz equation
Schwartz equation for 
paediatric patients
Table 3. Description of used equations for calculating eGFR by type of medical biochemistry laboratory, method for serum creati-
nine measurement, reporting units and additional comments.*
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Equation used for 
calculating eGFR Reporting eGFR Comment
General / county / 
special hospital
Compensated Jaffe 
aligned with IDMS 
method
MDRD equation for 
standardized creatinine
Values above 60 mL/
min/1.73 m2 report as 
>60 mL/min/1.73 m2
-
General / county / 
special hospital
Compensated Jaffe 
aligned with IDMS 
method
MDRD equation for 
standardized creatinine
Values above 60 mL/
min/1.73 m2 report as 
>60 mL/min/1.73 m2 for 
MDRD equation
Wrong method for calculating 







aligned with IDMS 
method
MDRD equation for 
standardized creatinine
Values above 60 mL/
min/1.73 m2 report as 
>60 mL/min/1.73 m2 -





Uncompensated Jaffe MDRD equation for standardized creatinine
Values above 60 mL/
min/1.73 m2 report as 
>60 mL/min/1.73 m2
Wrong equation used for 
calculating eGFR regards to 







aligned with IDMS 
method
Schwartz equation for 
paediatric patients
Values above 60 mL/







Uncompensated Jaffe CKD-EPI equation All values for eGFR report as the exact number
Wrong equation used for 
calculating eGFR regards to 
the used method for creatinine 
measurement
* There are 20 laboratories (out of 78 that measure serum creatinine concentrations) which report eGFR.
eGFR – estimated glomerular filtration rate; IDMS – isotope dilution mass spectrometry; MDRD – Modification of Diet in Renal 
Disease Study; CKD-EPI – Chronic Kidney Disease Epidemiology Collaboration
method for serum creatinine measurement, re-
porting units and additional comments are shown 
in Table 3.
The most prevalent equation for calculating eGFR 
is Modification of Diet in Renal Disease Study 
(MDRD) equation for standardized creatinine 
(15/20). 5 laboratories are using more than one 
equation for calculating eGFR. 4 of them are using 
Schwartz equation for paediatric patients in com-
bination with MDRD or Chronic Kidney Disease Ep-
idemiology Collaboration (CKD-EPI) equation for 
adults. Only one laboratory combines MDRD 
equation for standardized creatinine with CKD-EPI 
equation for adult population. In the Table 3, it 
was clearly shown that there were some answers 
indicating using the MDRD equation for standard-
ized creatinine with the results of serum creatinine 
measured with non-standardized uncompensated 
Jaffé method (2/20), and reporting of results for 
eGFR calculated with MDRD equation as an exact 
number regardless of eGFR value (4/20). 
Albuminuria/proteinuria
Majority of laboratories that participated in the 
survey do not measure urine albumin or protein 
(58/80). Out of those who measure urine albumin 
or protein the most prevalent method is immuno-
turbidimetric method (12/14) for urine albumin 
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Please specify your 
reference interval 
(cut-off value) for 
urine protein














value) for urine 
albumin
urine protein both 24-hour urine 




< 0.15 g/dU - - -
urine protein both 24-hour urine 







both urine protein 
and urine albumin
both 24-hour urine 





< 15.0 mg/mmol 
< 0.15 g/24 h
both 24-hour urine 





< 3.0 mg/mmol 
< 30 mg/24 h




g/24 h < 0.08 g/24 h both 24-hour urine 





M: < 2.5 mg/mmol 
F: < 3.5 mg/mmol 
< 30 mg/24h
both urine protein 
and urine albumin
both 24-hour urine 





< 20 mg/mmol 
< 0.15 g/dU
both 24-hour urine 





< 5 mg/mmol 
< 30 mg/dU
urine protein both 24-hour urine 







< 7.9 mg/mmol 
< 70 mg/g 
0.024–0.141 g/dU
- - -
both urine protein 
and urine albumin
both 24-hour urine 












M: < 2.5 mg/mmol 
F: < 3.5 mg/mmol 
< 30 mg/24h







both urine protein 
and urine albumin
both 24-hour urine 




0.05–0.08 g/24h both 24-hour urine 





< 3 g/mol 
< 30 mg/dU
urine protein 24-hour urine 
sample
g/dU 0.028–0.141 g/dU - - -




g/24 h < 0.08 g/24h 24-hour urine 
sample
mg/24 h < 300 mg/24 h






< 0.15 g/24h 
0.013–0.094 g/L
both 24-hour urine 




< 30 mg/24 h 
< 20 mg/L
Table 4. Description of albuminuria/proteinuria assessment regarding preferred sample type, reporting units and reference inter-
vals (or cut-offs) in Croatian medical biochemistry laboratories (questions 10,11,12,20,21,22,23).*
and colorimetric method for urine protein (16/22), 
respectively. There is a large heterogeneity among 
type of sample recommended for measuring urine 
albumin or protein and reporting units, conse-
quently. Survey results are summarized in Table 4.
The results indicate that assessment of albuminu-
ria and proteinuria in a large number of laborato-
ries is still performed in 24-hour urine samples. 
Predominant manufacturer of reagents used for 
measuring urine albumin or protein is Beckman 
Coulter (14/22 for urine protein, and 8/14 for urine 
albumin). 
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Please specify your 
reference interval 
(cut-off value) for 
urine protein














value) for urine 
albumin
both urine protein 
and urine albumin
both 24-hour urine 







< 17 mg/mmol 
30–150 mg/g 
30–150 mg/dU
both 24-hour urine 







< 3.4 mg/mmol 
2–30 mg/g 
2–30 mg/dU




g/dU < 0.2 g/dU both 24-hour urine 






both urine protein 
and urine albumin
both 24-hour urine 




0.028–0.141 g/dU both 24-hour urine 






urine protein both 24-hour urine 
and random urine 
sample
g/dU < 0.15 g/dU - - -
urine protein 24-hour urine 
sample
g/24 h 0.02–0.15 g/24h - - -
urine protein both 24-hour urine 





- - - -







<100 mg/g  
<150 mg/dU
both 24-hour urine 





< 20 mg/g 
< 25 mg/dU
both urine protein 
and urine albumin
both 24-hour urine 
and random urine 
sample
g/dU <0.15 g/dU both 24-hour urine 









g/dU 0.028–0.141 g/dU both 24-hour urine 










g/dU 0.028–0.141 g/dU first morning spot 
urine sample
mg/L < 20 mg/L
* N = 14 laboratories that measure both urine protein and urine albumin; N=10 laboratories that measure only urine protein
Additional education
76 (out of 80) responders declared their interest in 
further education in the field of implementation of 
clinical guidelines into every day routine practice.
Discussion
This is the first study to give insight about labora-
tory diagnostics of chronic kidney disease in Croa-
tian medical biochemistry laboratories. The mo-
tive for this study was the new updated KDIGO 
2012 Clinical Practice Guideline for the Evaluation 
and Management of Chronic Kidney Disease in 
which the role of laboratory medicine is of great 
importance. The key prerequisite for the screening 
of CKD are two simple laboratory tests: eGFR and 
assessment of albuminuria (or proteinuria) (5). The 
American Society of Nephrology strongly recom-
mends all adults to undergo routine screening for 
CKD and some data suggest that screening for 
CKD is cost-effective in patients with diabetes and 
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hypertension (6,7). However, there are no national 
Croatian guidelines regarding this area of labora-
tory medicine, as in some other countries through-
out the world (2,3,8,9). This study describes current 
status of harmonization of creatinine and albumi-
nuria (proteinuria) measurement in Croatian medi-
cal biochemistry laboratories.
Harmonization process regarding creatinine 
standardization in Croatia started in 2010 with the 
recommendations for revision of creatinine meth-
ods and reference intervals published by CCMB (4). 
This initial process was followed by a course about 
harmonization in laboratory medicine in 2011 (10). 
However, it is obvious from the survey results that 
creatinine standardization process in Croatian lab-
oratories is not finished and only minority of labo-
ratories automatically report eGFR values. The big-
gest problem raised from this survey results is a 
fact that there is discrepancy between methods 
used for creatinine measurement and creatinine 
reference intervals, i.e. reference intervals for 
standardized creatinine were used for creatinine 
results measured by non-standardized methods, 
and vice versa. Similar problem was observed with 
equations used for calculating eGFR. Also, report-
ing values for eGFR are not as recommended (all 
values greater than 60 mL/min/1.73 m2 report as 
„> 60 mL/min/1.73 m2“, but are given as the exact 
calculated number for MDRD equation). Very small 
number of laboratories use CKD-EPI equation rec-
ommended by KDIGO guideline for calculating 
eGFR. These results can have serious implications 
on patient health and there is a need for better 
regulation in this area of laboratory work. One of 
the possible approaches can be through pre- and 
post-analytical modules of Croatian national exter-
nal quality assessment scheme which is in the do-
main of Croatian Centre for Quality Assessment in 
Laboratory Medicine (CROQALM).
Survey results about biomarkers of kidney dam-
age show even higher heterogeneity among Croa-
tian laboratories. There are no recommendations 
about preferred type of urine sample for an initial 
screening, and large part of laboratories perform 
analyses in 24-hour urine samples, regardless of all 
known disadvantages (11). There is a high variabili-
ty of reporting units; some laboratories still report 
absolute concentrations of urine albumin, regard-
less of the type of urine sample, although there 
were some efforts made in the area of laboratory 
diagnostics of diabetic nephropathy to standard-
ize type of samples and reporting units used for 
measuring urine albumin (12). One of the major 
problems is the fact that laboratories in primary 
health care institutions do not measure urine albu-
min or protein at all.
Some of these problems were acknowledged at a 
course of laboratory diagnostics of chronic kidney 
disease held in 2013. However this survey shows 
that in spite of numerous education efforts from 
our national associations, the policies and practic-
es concerning CKD in Croatian laboratories are nei-
ther uniform nor harmonized (13). For this reason 
we concluded that education must start at the be-
ginning and provide simple and understandable 
recommendations and guidelines for initiative 
screening of CKD followed by comprehensive edu-
cation through our national associations. Such 
conclusion is supported by a high number of re-
sponders that stated they are interested in further 
education in the field of implementation of clinical 
guidelines into everyday routine practice. Howev-
er, the most troubling fact is that all 4 survey par-
ticipants that declared against further education, 
had discrepancy between serum creatinine meas-
urement methods and used reference intervals. 
One of the goals of this study is to raise awareness 
amongst Croatian laboratories about critical 
points in this area of laboratory medicine.
This study has several limitations, similar to those 
observed in a study conducted by Dukić and 
Šimundić (14): the survey was self reported and 
participants might not be providing the accurate 
and reliable information about the real situation; 
there was a low number of responders and major-
ity were from primary health care institutions. 
Conclusions
It is evident from the survey results that laboratory 
diagnostics of chronic kidney disease in Croatia is 
not standardized. Laboratories still use non-stand-
ardized methods for creatinine measurement and 
they do not report eGFR values. Most laboratories 
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still measure urine albumin or protein in 24-hour 
urine sample, which is also the only recommend-
ed sample in some laboratories. There is a large 
heterogeneity in reference intervals and types of 
units in albuminuria (or proteinuria) measurement. 
It is essential to provide a framework for nation-
wide harmonization and standardization of labo-
ratory procedures in this area of laboratory medi-
cine. 
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